Progress in Photoactive Biomaterial-Based Synergistic Combination Phototherapy
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: 1 July 2024 | Viewed by 120
Special Issue Editor
Special Issue Information
Dear Colleagues,
Photothermal therapy (PTT) and photodynamic therapy (PDT) utilize photosensitive materials with high photothermal conversion efficiency or reactive oxygen species (ROS) production rate, achieving targeted treatment of diseases (including infections and cancer) upon light exposure. These photonics strategies have the advantages of a short treatment time, significant curative effect and few side effects. In addition, they can promote the oxidation of microorganisms' biomolecules, ultimately leading to their inactivation. With the development of phototherapy, various biomaterials are used as photosensitive drugs or effective drug carriers to improve the effect of phototherapy.
We extend an invitation for the contribution to our upcoming Special Issue of Pharmaceutics, which focuses on photoactive biomaterial-mediated photothermal therapy and photodynamic therapy. These biomaterials possess the unique ability to interact with light, thereby engendering pharmaceutical properties against cancer cells, disease cells and microorganisms. In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following: photoactive materials, phototherapy, photodynamic therapy and photothermal therapy.
We look forward to receiving your contributions.
Dr. Lucas D. Dias
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- photoactive biomaterials
- targeted drug therapy
- phototherapy
- photodynamic therapy
- biopharmaceutics
- cancer therapy
- antimicrobial therapy
